Qiao Jie

[Expert Profile] Qiao Jie, Chief Physician, Professor, Doctoral Supervisor, Academician of the Chinese Academy of Engineering, is an authoritative expert in reproductive medicine in China, working at Peking University Third Hospital. She has long been dedicated to clinical diagnosis, treatment, and scientific research of difficult infertility and reproductive endocrine genetic diseases, and is an important leading figure in reproductive medicine both domestically and internationally.

[Education & Career] Professor Qiao Jie graduated from Beijing Medical University (now Peking University Health Science Center), completed systematic clinical training at Peking University Third Hospital, and further studied at famous international reproductive medicine centers. She has long served as President of Peking University Third Hospital, and was elected as an Academician of the Chinese Academy of Engineering in 2017. She has held important academic positions including Chair of the Reproductive Medicine Professional Committee of the Chinese Medical Doctor Association, and has presided over major projects including the National Key R&D Program. She is an academic leader in the field of reproductive medicine in China.

[Areas of Expertise] Professor Qiao specializes in the diagnosis and treatment of various difficult infertility cases, standardized application of assisted reproductive technology (in vitro fertilization-embryo transfer, preimplantation genetic diagnosis, etc.), as well as diagnosis, treatment, and genetic counseling of reproductive endocrine diseases and reproductive genetic disorders (chromosomal abnormalities, single gene disorders). She has profound expertise in developing individualized fertility treatment plans for complex cases such as polycystic ovary syndrome, repeated implantation failure, and advanced age infertility. She excels at managing difficult patients with "years of infertility and multiple failed fertility treatments," helping countless families fulfill their dream of having children.

[Academic Achievements & Industry Contributions] Professor Qiao has led the establishment of an internationally leading reproductive medicine clinical and basic research platform, systematically conducting research on oocyte and embryo development mechanisms and assisted reproductive technology safety, and led the establishment of a Chinese embryo development and reproductive disease gene database, with findings published in top international journals. She has led the development of Chinese assisted reproductive technology-related standards and expert consensus statements, promoted standardized application of new technologies such as preimplantation genetic diagnosis, and led the construction of a national reproductive medicine quality control system, making outstanding contributions to the development of reproductive medicine and high-quality population development in China.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of reproductive medicine clinical work, Professor Qiao has led her team in completing hundreds of thousands of assisted reproductive cycles, helping countless infertile families welcome new lives. She has received multiple national awards including the National Science and Technology Progress Award, trained a large number of reproductive medicine leaders, and has been repeatedly invited to deliver keynote reports at international academic conferences. She is a truly deserving authoritative expert in the field of reproductive medicine in China, deeply admired by patients and peers alike.

[Honors & Reputation] Professor Qiao Jie serves as President of Peking University Third Hospital and Chair of the Reproductive Medicine Professional Committee of the Chinese Medical Doctor Association, among other academic positions. She was elected as an Academician of the Chinese Academy of Engineering in 2017, has presided over national-level major projects including the National Key R&D Program, and is an authoritative expert in the field of reproductive medicine in China. She has led the establishment of an internationally leading reproductive medicine clinical and basic research platform, systematically conducting research on oocyte and embryo development mechanisms and assisted reproductive technology safety, and led the establishment of a Chinese embryo development and reproductive disease gene database, with findings published in top international journals and receiving the National Science and Technology Progress Award. Leading her team, she has completed hundreds of thousands of assisted reproductive cycles, helping countless families fulfill their dream of having children. She is deeply trusted by patients and respected by peers alike.